Parkinson's Disease

European guidelines on invasive therapies for Parkinson’s disease 3:02
European guidelines on invasive therapies for Parkinson’s disease
Francisco Cardoso • 15 Sep 2022
An overview on late-stage Parkinson’s disease 2:54
An overview on late-stage Parkinson’s disease
Margherita Fabbri • 17 Sep 2022
Recent developments in Parkinson’s disease 2:22
Recent developments in Parkinson’s disease
Francisco Cardoso • 15 Sep 2022
Efforts to increase training in movement disorders 1:47
Efforts to increase training in movement disorders
Francisco Cardoso • 15 Sep 2022
Neuroinflammation and immune changes in prodromal Parkinson’s disease 1:26
Neuroinflammation and immune changes in prodromal Parkinson’s disease
Marina Romero-Ramos • 17 Sep 2022
CNS infiltration in Parkinson’s disease 1:08
CNS infiltration in Parkinson’s disease
Marina Romero-Ramos • 17 Sep 2022
Updated guideline on the treatment of Parkinson’s disease 1:49
Updated guideline on the treatment of Parkinson’s disease
Francisco Cardoso • 15 Sep 2022
Immune-related biomarkers for Parkinson’s disease 1:33
Immune-related biomarkers for Parkinson’s disease
Marina Romero-Ramos • 17 Sep 2022
ASOs as therapeutic strategies in movement disorders 2:13
ASOs as therapeutic strategies in movement disorders
Tiago Outeiro • 17 Sep 2022
The role of neuroinflammatory responses in Parkinson’s disease 1:37
The role of neuroinflammatory responses in Parkinson’s disease
Tiago Outeiro • 17 Sep 2022
The symptomatic management of Parkinson’s disease 1:08
The symptomatic management of Parkinson’s disease
Margherita Fabbri • 17 Sep 2022
Research advancements in the pathogenesis of Parkinson’s disease 3:11
Research advancements in the pathogenesis of Parkinson’s disease
Serge Przedborski • 16 Sep 2022
COMT inhibitors for Parkinson’s disease: clinical updates 1:06
COMT inhibitors for Parkinson’s disease: clinical updates
Margherita Fabbri • 17 Sep 2022
Assessing the efficacy of antibodies targeting α-synuclein 1:38
Assessing the efficacy of antibodies targeting α-synuclein
Fabrizio Stocchi • 16 Oct 2022
Barriers to effective symptom management in Parkinson’s disease 0:56
Barriers to effective symptom management in Parkinson’s disease
Per Odin • 17 Sep 2022
MSA: challenges with early diagnosis 2:31
MSA: challenges with early diagnosis
Carlo Colosimo • 16 Sep 2022
The content of VJNeurology is intended for healthcare professionals